Reply to Shun-Fa Hung, Shyi-Chun Yii, and Shiu-Dong Chung's Letter to the Editor re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.012

被引：0

作者：

He, Peng ^{[1
]}

Zhou, Xiaozhou ^{[1
]}

Chen, Zhiwen ^{[1
]}

机构：

[1] Third Mil Med Univ, Urol Inst PLA, Southwest Hosp, Dept Urol, 29 Gaotanyan St, Chongqing, Peoples R China

来源：

EUROPEAN UROLOGY | 2022年 / 81卷 / 05期

关键词：

D O I：

10.1016/j.eururo.2022.01.038

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E119 / E119

页数：1

共 6 条

[1] Re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.012
Hung, Shun-Fa
Yii, Shyi-Chun
Chung, Shiu-Dong
[J]. EUROPEAN UROLOGY, 2022, 81 (05) : E118 - E118
[2] Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factordefined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2023.05.023
Feng, Mingxiao
Matoso, Andres
Epstein, Gabriel
Fong, Megan
Park, Yong Hyun
Gabrielson, Andrew
Patel, Sunil
Czerniak, Bagdan
Comperat, Eva
Hoffman-Censits, Jeannie
Kates, Max
Kim, Seungchan
McConkey, David
Choi, Woonyoung
[J]. EUROPEAN UROLOGY, 2024, 85 (04) : e122 - e123
[3] Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012
Kerkmeijer, Linda G. W.
Pos, Floris J.
van der Heide, Uulke A.
Israel, Bas
Draulans, Cedric
Haustermans, Karin
[J]. EUROPEAN UROLOGY, 2022, 81 (06) : E147 - E148
[4] Reply to Fabio Campodonico, Francesca Mattioli, and Carlo Introini's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003
Tan, Wei Shen
Kelly, John D.
HIVEC-II Trial Team
[J]. EUROPEAN UROLOGY, 2023, 83 (01) : E29 - E30
[5] Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Becker, Russell E. N.
Baras, Alex
Bivalacqua, Trinity J.
[J]. EUROPEAN UROLOGY, 2021, 79 (02) : E58 - E59
[6] Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2022.08.003
Tan, Wei Shen
Mustard, Connor
Kelly, John D.
[J]. EUROPEAN UROLOGY, 2023, 83 (02) : E48 - E49

← 1 →